Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins

Chemistry and Biology

Volumn 16, Issue 6, 2009, Pages 624-632

  Oddi, Sergio ^a,b   Fezza, Filomena ^b,c   Pasquariello, Nicoletta ^a   D'Agostino, Antonella ^a   Catanzaro, Giuseppina ^a,b   De Simone, Chiara ^b,c   Rapino, Cinzia ^a   Finazzi Agrò, Alessandro ^c   Maccarrone, Mauro ^a,b  

^a UNIVERSITY OF TERAMO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

CELLBIO; CHEMBIO

Indexed keywords

ALBUMINOID; AMIDE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; CARRIER PROTEIN; HEAT SHOCK PROTEIN 70;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; CYTOSOL; HUMAN; METABOLISM; MOUSE; PROTEIN BINDING; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ALBUMINS; AMINO ACID SEQUENCE; ANIMALS; ARACHIDONIC ACIDS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE, TUMOR; CYTOSOL; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MICE; POLYUNSATURATED ALKAMIDES; PROTEIN BINDING;

EID: 67649470418     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.05.004     Document Type: Article

References (61)

1. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., and Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277 (1997) 1094-1097
2. Berghuis P., Dobszay M.B., Wang X., Spano S., Ledda F., Sousa K.M., Schulte G., Ernfors P., Mackie K., Paratcha G., et al. Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc. Natl. Acad. Sci. USA 102 (2005) 19115-19120
3. Bojesen I.N., and Hansen H.S. Binding of anandamide to bovine serum albumin. J. Lipid Res. 44 (2003) 1790-1794
4. Breyer E.D., Howard S., Raje N., Allison S., Apkarian R., Brown W.V., and Strasters J.K. Study of lipid and apolipoprotein binding interactions using vesicle affinity capillary electrophoresis. Anal. Chem. 75 (2003) 5160-5169
5. Casanova M.L., Blazquez C., Martinez-Palacio J., Villanueva C., Fernandez-Acenero M.J., Huffman J.W., Jorcano J.L., and Guzman M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J. Clin. Invest. 111 (2003) 43-50
6. Dainese E., Oddi S., Bari M., and Maccarrone M. Modulation of the endocannabinoid system by lipid rafts. Curr. Med. Chem. 14 (2007) 2702-2715
7. De Petrocellis L., Bisogno T., Davis J.B., Pertwee R.G., and Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 483 (2000) 52-56
8. Desarnaud F., Cadas H., and Piomelli D. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 270 (1995) 6030-6035
9. Deutsch D.G., Glaser S.T., Howell J.M., Kunz J.S., Puffenbarger R.A., Hillard C.J., and Abumrad N. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J. Biol. Chem. 276 (2001) 6967-6973
10. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce?. Nat. Rev. Drug Discov. 7 (2008) 438-455
11. Drin G., Mazel M., Clair P., Mathieu D., Kaczorek M., and Temsamani J. Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. Eur. J. Biochem. 268 (2001) 1304-1314
12. Fegley D., Kathuria S., Mercier R., Li C., Goutopoulos A., Makriyannis A., and Piomelli D. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc. Natl. Acad. Sci. USA 101 (2004) 8756-8761
13. Fezza F., Oddi S., Di Tommaso M., De Simone C., Rapino C., Pasquariello N., Dainese E., Finazzi-Agrò A., and Maccarrone M. Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation. J. Lipid Res. 49 (2008) 1216-1223
14. Forneris F., and Mattevi A. Enzymes without borders: mobilizing substrates, delivering products. Science 321 (2008) 213-216
15. Fowler C.J., Holt S., Nilsson O., Jonsson K.O., Tiger G., and Jacobsson S.O. The endocannabinoid signaling system: pharmacological and therapeutic aspects. Pharmacol. Biochem. Behav. 81 (2005) 248-262
16. Fowler C.J., Tiger G., Ligresti A., Lopez-Rodriguez M.L., and Di Marzo V. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis-a difficult issue to handle. Eur. J. Pharmacol. 492 (2004) 1-11
17. Fuchs E. Epidermal differentiation. Curr. Opin. Cell Biol. 2 (1990) 1028-1035
18. Furuhashi M., and Hotamisligil G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 7 (2008) 489-503
19. Gacad M.A., and Adams J.S. Proteins in the heat shock-70 family specifically bind 25-hydroxyvitamin D3 and 17beta-estradiol. J. Clin. Endocrinol. Metab. 83 (1998) 1264-1267
20. Gazzara J.A., Phillips M.C., Lund-Katz S., Palgunachari M.N., Segrest J.P., Anantharamaiah G.M., and Snow J.W. Interaction of class A amphipathic helical peptides with phospholipid unilamellar vesicles. J. Lipid Res. 38 (1997) 2134-2146
21. Gehrmann M., Liebisch G., Schmitz G., Anderson R., Steinem C., De Maio A., Pockley G., and Multhoff G. Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS ONE 3 (2008) e1925
22. Giuffrida A., Rodriguez de Fonseca F., and Piomelli D. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal. Biochem. 280 (2000) 87-93
23. Glaser S.T., Abumrad N.A., Fatade F., Kaczocha M., Studholme K.M., and Deutsch D.G. Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. USA 100 (2003) 4269-4274
24. Glaser S.T., Kaczocha M., and Deutsch D.G. Anandamide transport: a critical review. Life Sci. 77 (2005) 1584-1604
25. Gorg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., and Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21 (2000) 1037-1053
26. Hanada K., Kumagai K., Yasuda S., Miura Y., Kawano M., Fukasawa M., and Nishijima M. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426 (2003) 803-809
27. Hasse S., Kothari S., Rokos H., Kauser S., Schurer N.Y., and Schallreuter K.U. In vivo and in vitro evidence for autocrine DCoH/HNF-1alpha transcription of albumin in the human epidermis. Exp. Dermatol. 14 (2005) 182-187
28. Hillard C.J., and Jarrahian A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids 108 (2000) 123-134
29. Hillard C.J., and Jarrahian A. Cellular accumulation of anandamide: consensus and controversy. Br. J. Pharmacol. 140 (2003) 802-808
30. Ibdah J.A., Krebs K.E., and Phillips M.C. The surface properties of apolipoproteins A-I and A-II at the lipid/water interface. Biochim. Biophys. Acta 1004 (1989) 300-308
31. Jacobsson S.O., and Fowler C.J. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. Br. J. Pharmacol. 132 (2001) 1743-1754
32. Kaczocha M., Hermann A., Glaser S.T., Bojesen I.N., and Deutsch D.G. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. J. Biol. Chem. 281 (2006) 9066-9075
33. Kaczocha M., Glaser S.T., and Deutsch D.G. Identification of intracellular carriers for the endocannabinoid anandamide. Proc. Natl. Acad. Sci. USA 106 (2009) 6375-6380
34. Katz J., Bonorris G., and Sellers A.L. Extravascular albumin in human tissues. Clin. Sci. 39 (1970) 725-729
35. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5 (2005) 400-411
36. Lauckner J.E., Jensen J.B., Chen H.Y., Lu H.C., Hille B., and Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc. Natl. Acad. Sci. USA 105 (2008) 2699-2704
37. Leask A., Rosenberg M., Vassar R., and Fuchs E. Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription. Genes Dev. 4 (1990) 1985-1998
38. Maccarrone M., Bari M., Lorenzon T., Bisogno T., Di Marzo V., and Finazzi-Agrò A. Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem. 275 (2000) 13484-13492
39. Maccarrone M., Di Rienzo M., Battista N., Gasperi V., Guerrieri P., Rossi A., and Finazzi-Agrò A. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J. Biol. Chem. 278 (2003) 33896-33903
40. Mamelak D., and Lingwood C. Expression and sulfogalactolipid binding specificity of the recombinant testis-specific cognate heat shock protein 70. Glycoconj. J. 14 (1997) 715-722
41. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
42. McFarland M.J., and Barker E.L. Anandamide transport. Pharmacol. Ther. 104 (2004) 117-135
43. McFarland M.J., Porter A.C., Rakhshan F.R., Rawat D.S., Gibbs R.A., and Barker E.L. A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. J. Biol. Chem. 279 (2004) 41991-41997
44. Menguy T., Chenevois S., Guillain F., le Maire M., Falson P., and Champeil P. Ligand binding to macromolecules or micelles: use of centrifugal ultrafiltration to measure low-affinity binding. Anal. Biochem. 264 (1998) 141-148
45. Moore S.A., Nomikos G.G., Dickason-Chesterfield A.K., Schober D.A., Schaus J.M., Ying B.P., Xu Y.C., Phebus L., Simmons R.M., Li D., et al. Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc. Natl. Acad. Sci. USA 102 (2005) 17852-17857
46. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
47. Oddi S., Bari M., Battista N., Barsacchi D., Cozzani I., and Maccarrone M. Confocal microscopy and biochemical analysis reveal spatial and functional separation between anandamide uptake and hydrolysis in human keratinocytes. Cell. Mol. Life Sci. 62 (2005) 386-395
48. Oddi S., Fezza F., Pasquariello N., De Simone C., Rapino C., Dainese E., Finazzi-Agrò A., and Maccarrone M. Evidence for the intracellular accumulation of anandamide in adiposomes. Cell. Mol. Life Sci. 65 (2008) 840-850
49. Ortar G., Ligresti A., De Petrocellis L., Morera E., and Di Marzo V. Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem. Pharmacol. 65 (2003) 1473-1481
50. Ortega-Gutierrez S., Hawkins E.G., Viso A., Lopez-Rodriguez M.L., and Cravatt B.F. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Biochemistry 43 (2004) 8184-8190
51. Paradisi A., Pasquariello N., Barcaroli D., and Maccarrone M. Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J. Biol. Chem. 283 (2008) 6005-6012
52. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4 (2003) 873-884
53. Rabilloud T., Asselineau D., and Darmon M. Presence of serum albumin in normal human epidermis: possible implications for the nutrition and physiology of stratified epithelia. Presence of albumin in epidermis. Mol. Biol. Rep. 13 (1988) 213-219
54. Rakhshan F., Day T.A., Blakely R.D., and Barker E.L. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J. Pharmacol. Exp. Ther. 292 (2000) 960-967
55. Ruiz-Llorente L., Ortega-Gutierrez S., Viso A., Sanchez M.G., Sanchez A.M., Fernandez C., Ramos J.A., Hillard C., Lasuncion M.A., Lopez-Rodriguez M.L., et al. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. Br. J. Pharmacol. 141 (2004) 457-467
56. Soccio R.E., and Breslow J.L. Intracellular cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1150-1160
57. Starowicz K., Nigam S., and Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 114 (2007) 13-33
58. Sun Y., and Bennett A. Cannabinoids: a new group of agonists of PPARs. PPAR Res. 2007 (2007) 23513
59. Ueda N., Okamoto Y., and Morishita J. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines. Life Sci. 77 (2005) 1750-1758
60. Uittenbogaard A., Ying Y., and Smart E.J. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J. Biol. Chem. 273 (1998) 6525-6532
61. Wang H., Dey S.K., and Maccarrone M. Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility. Endocr. Rev. 27 (2006) 427-448